Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (17)

2023

  1. Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated with Internal Fistulizing Disease: BIOSCOPE Study from GETECCU

    American Journal of Gastroenterology, Vol. 118, Núm. 6, pp. 1036-1046

2022

  1. Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

    Frontiers in Medicine, Vol. 9

  2. Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study

    Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736

  3. Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU

    Journal of Crohn's & colitis, Vol. 16, Núm. 7, pp. 1049-1058

  4. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab

    Journal of Clinical Medicine, Vol. 11, Núm. 15

2020

  1. Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: The VERNE study

    BMJ Open Gastroenterology, Vol. 7, Núm. 1

2019

  1. Prevalence and Factors Associated with Fatigue in Patients with Inflammatory Bowel Disease: A Multicentre Study

    Journal of Crohn's and Colitis, Vol. 13, Núm. 8, pp. 996-1002

2018

  1. Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes the TRIGR randomized clinical trial

    JAMA - Journal of the American Medical Association, Vol. 319, Núm. 1, pp. 38-48

  2. Long-term safety of in utero exposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study

    American Journal of Gastroenterology, Vol. 113, Núm. 3, pp. 396-403

  3. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients

    Gastroenterologia y Hepatologia

2016

  1. Outcomes of medical and surgical therapy for entero-urinary fistulas in Crohn's disease

    Journal of Crohn's and Colitis, Vol. 10, Núm. 6, pp. 657-662

2014

  1. Disease severity in familial cases of IBD

    Journal of Crohn's and Colitis, Vol. 8, Núm. 3, pp. 234-239

  2. Risk of colectomy in patients with ulcerative colitis under thiopurine treatment

    Journal of Crohn's and Colitis, Vol. 8, Núm. 10, pp. 1287-1293

2013

  1. Does smoking influence Crohn's disease in the biologic era? the TABACROHN study

    Inflammatory Bowel Diseases, Vol. 19, Núm. 1, pp. 23-29

  2. High smoking cessation rate in Crohn's disease patients after physician advice - The TABACROHN Study

    Journal of Crohn's and Colitis, Vol. 7, Núm. 3, pp. 202-207

2011

  1. Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab

    Alimentary Pharmacology and Therapeutics, Vol. 33, Núm. 3, pp. 340-348

1999

  1. Molecular analysis in familial neurohypophyseal diabetes insipidus: Early diagnosis of an asymptomatic carrier

    Journal of Clinical Endocrinology and Metabolism, Vol. 84, Núm. 9, pp. 3351-3354